Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to Nisotirostide.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide NCT06897475 | Nisotirostide | Phase 2 | Recruiting | Eli Lilly and Company | 200 | May 2027 | Nov 4, 2026 |
| A Study of LY3457263 in Obese Participants NCT05582096 | Nisotirostide | Phase 1 | Completed | Eli Lilly and Company | 38 | Jun 8, 2023 | Jul 18, 2023 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.